CCL8 and neoplasm: Also, reduced CD44 and CD31 expressions were observed in CCL8 antibody-treated tumors (Fig. 4J, K), suggesting that the blocking of CCL8 reduced the THP-1-derived M2-like macrophages-induced increase of tumor onset and angiogenesis.